Cardiovascular diseases (CVD) compromises a group of heart and blood vessels disorders with high impact on human health and wellbeing. Curcumin (CUR) have demonstrated beneficial effects on these group of diseases that represent a global burden with a prevalence that continues increasing progressively. Pre- and clinical studies have demonstrated the CUR effects in CVD through its anti-hypercholesterolemic and anti-atherosclerotic effects and its protective properties against cardiac ischemia and reperfusion. However, the CUR therapeutic limitation is its bioavailability. New CUR nanomedicine formulations are developed to solve this problem. The present article aims to discuss different studies and approaches looking into the promising role of nanotechnology-based drug delivery systems to deliver CUR and its derivatives in CVD treatment, with an emphasis on their formulation properties, experimental evidence, bioactivity, as well as challenges and opportunities in developing these systems.
Fungi possess diverse metabolic pathways and enzymatic systems, enabling them to degrade a broad spectrum of environmental pollutants, including heavy metals, hydrocarbons, and synthetic dyes. This review highlights recent advancements in fungal bioremediation strategies, with a detailed focus on molecular enzymatic pathways such as ligninolytic and cytochrome P450 systems. It also examines the synergistic role of fungal consortia and plant-fungal interactions in enhancing pollutant degradation efficiency and field adaptability. Fungal consortia are cooperative communities of multiple fungal species that work synergistically, often exhibiting enhanced abilities to degrade complex pollutants compared to individual strains due to their complementary enzymatic activities and interactions (Rezaei Z, Moghimi H in Ecotoxicol Environ Saf 280: 116543, 2024). To better understand these complex interactions and the molecular pathways involved in pollutant degradation and environmental adaptation, researchers increasingly rely on omics technologies which includes genomics, transcriptomics, proteomics, and metabolomics. White rot basidiomycetes produce laccases and class II peroxidases that degrade organic pollutants. The integration of fungal genomics, omics technologies, and nanobiotechnology-based delivery systems is also critically examined. Importantly, this review outlines the current challenges in scalability, substrate specificity, and bioreactor design, while suggesting future research directions, including genetic modification and optimization of consortia compositions. By bridging molecular mechanisms with field-level implementation, this work provides new insights into the potential of fungi as efficient, adaptable, and sustainable agents for environmental remediation.
7 December 2020 in Current Pharmaceutical Biotechnology
Background: Floral has diversity and unique nature due to the complex structure and component. Alpinia is an important genus of the Zingiberaceae family having complex taxonomical diversity. The presence of many unique bioactive molecules makes this genus, a pharmaceutically important genus. They provide a wide range of medicinal properties, including traditional remedies to modern therapeutic applications. Methods: Extracts of Alpinia mostly contain bioactive molecules and secondary metabolites such as polyphenolics, tannins, flavonoids and other therapeutically important compounds. These bioactive molecules are biologically active, treating against inflammation, cancer, arterial hypertension, and other deadly diseases. Results: These bioactive molecules can act as natural enzyme inhibitors for some of the deadly diseases and can block the pathway for metabolic activities. In addition, these genera have played a major role in multidisciplinary studies of phytochemistry, ethnobotany, and pharmacological aspects in day-to-day life. Conclusion: Therefore, this review highlights the fewer known facts of the genus Alpinia in terms of bioactive molecules and its significant therapeutic applications to help in combating major diseases of humans.